Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics
Authors
Keywords
Mesenchymal stem cells, COVID-19, SARS-CoV-2, Immunomodulation, Acute respiratory distress syndrome, ACE-2 receptor, Lung fibrosis
Journal
LIFE SCIENCES
Volume 263, Issue -, Pages 118588
Publisher
Elsevier BV
Online
2020-10-10
DOI
10.1016/j.lfs.2020.118588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment
- (2020) Jiajia Chen et al. Engineering
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Genotype and phenotype of COVID-19: Their roles in pathogenesis
- (2020) Leila Mousavizadeh et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
- (2020) Christopher J. Rogers et al. Journal of Translational Medicine
- Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
- (2020) Alice Huertas et al. EUROPEAN RESPIRATORY JOURNAL
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells
- (2020) Bing Liang et al. MEDICINE
- COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
- (2020) Muhammad Adnan Shereen et al. Journal of Advanced Research
- Bats and Coronaviruses
- (2019) Arinjay Banerjee et al. Viruses-Basel
- Better therapeutic potential of bone marrow-derived mesenchymal stem cells compared with chorionic villi-derived mesenchymal stem cells in airway injury model
- (2019) Shimeng Ji et al. Regenerative Medicine
- Mesenchymal Stem Cells Increase Alveolar Differentiation in Lung Progenitor Organoid Cultures
- (2019) Kristen T. Leeman et al. Scientific Reports
- Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
- (2019) Andreas Robert Rudolf Weiss et al. Frontiers in Immunology
- The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity
- (2019) Yueyuan Zhou et al. Journal of Clinical Medicine
- Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells
- (2019) Lyndah Chow et al. Stem Cells Translational Medicine
- Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating HIF and ROS hypoxic signaling
- (2018) Olivier Bernard et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
- (2018) Peter Bader et al. BONE MARROW TRANSPLANTATION
- Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application
- (2018) Mengyuan Wang et al. Stem Cells International
- Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
- (2018) Michael A Matthay et al. Lancet Respiratory Medicine
- Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
- (2017) Antonio Galleu et al. Science Translational Medicine
- Mesenchymal Stem Cells: Time to Change the Name!
- (2017) Arnold I. Caplan Stem Cells Translational Medicine
- Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease
- (2016) Hongpeng Jia SHOCK
- Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review
- (2016) Lauralyn A. McIntyre et al. PLoS One
- Therapeutic Effects of Human Mesenchymal Stem Cell–derived Microvesicles in Severe Pneumonia in Mice
- (2015) Antoine Monsel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Human mesenchymal stem cells - current trends and future prospective
- (2015) Imran Ullah et al. BIOSCIENCE REPORTS
- Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4
- (2015) Xiaohui Fang et al. JOURNAL OF IMMUNOLOGY
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
- (2015) Jennifer G Wilson et al. Lancet Respiratory Medicine
- Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats
- (2014) KUN HUANG et al. Molecular Medicine Reports
- Human Decidua-Derived Mesenchymal Stem Cells Differentiate into Functional Alveolar Type II-Like Cells that Synthesize and Secrete Pulmonary Surfactant Complexes
- (2014) Alejandro Cerrada et al. PLoS One
- A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis
- (2014) Daniel C. Chambers et al. RESPIROLOGY
- A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
- (2013) Daniel J. Weiss et al. CHEST
- Preconditioning Enhances the Paracrine Effect of Mesenchymal Stem Cells in Preventing Oxygen-Induced Neonatal Lung Injury in Rats
- (2012) Paul Waszak et al. STEM CELLS AND DEVELOPMENT
- Phase II Trial: Undifferentiated Versus Differentiated Autologous Mesenchymal Stem Cells Transplantation in Egyptian Patients with HCV Induced Liver Cirrhosis
- (2011) Mervat El-Ansary et al. Stem Cell Reviews and Reports
- Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study
- (2010) J. Liang et al. ANNALS OF THE RHEUMATIC DISEASES
- 106: Phase 1 Trial of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients With Decompensated Liver Cirrhosis
- (2008) K. Alimoghaddam et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Sources of Stem Cells for Regenerative Medicine
- (2008) Jennifer Hipp et al. Stem Cell Reviews and Reports
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect
- (2008) Uwe M. Fischer et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation